Skip to content
SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%
Market News

Viatris to Buy Pacira BioSciences for $1.65 Billion

Business - Latest - Google News · October 8, 2026

Viatris to Buy Pacira BioSciences for $1.65 Billion  WSJViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal  ReutersWhy is Pacira BioSciences stock surging today? By Investing.com  Investing.com IndiaPCRX SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES PACIRA BIOSCIENCES, INC.  MorningstarViatris to snap up Pacira’s non-opioid pain pipeline for $1.65B  Fierce Pharma

View original source →

More News

Ministry of Finance says all public sector, regional rural banks to remain open on September 27
Maruti Finally Introduces AMT With CNG In Baleno, Swift & Dzire!
Bumble agrees to a $1.3B acquisition deal as online dating faces a reset
Options trading cannot drive market policy, says SEBI chief; SLBM revamp coming soon